Quarterly report pursuant to Section 13 or 15(d)

Note 19 - Segment Information: Schedule of Segment Information (Tables)

v3.21.1
Note 19 - Segment Information: Schedule of Segment Information (Tables)
3 Months Ended
Mar. 31, 2021
Tables/Schedules  
Schedule of Segment Information

 

 

 

Cannabis and

Medical

Marijuana

Segment

 

Facility

Operations

Related

 

Corporate,

Other and

Eliminations

 

Consolidated

Three months ended March 31, 2021

 

 

 

 

 

 

 

 

Net revenue

$

10,871

$

1,309,753

$

-

$

1,320,624

Operating income (loss)

 

6,125

 

(3,946)

 

(166,922)

 

(164,743)

Interest income

 

-

 

-

 

16,489

 

16,489

Interest expense

 

-

 

8,498

 

3,572

 

12,070

Property additions

 

-

 

6,595

 

1,264

 

7,859

Depreciation and amortization

 

-

 

7,960

 

1,461

 

9,421

Total assets

 

1,005,990

 

2,124,769

 

1,644,546

 

4,775,305

 

 

 

 

 

 

 

 

 

Three months ended March 31, 2020

 

 

 

 

 

 

 

 

Net revenue

$

12,538

$

1,136,924

$

-

$

1,149,462

Operating income (loss)

 

(8,905)

 

34,176

 

(261,994)

 

(236,723)

Interest income

 

24

 

-

 

19,379

 

19,403

Interest expense

 

-

 

8,471

 

(1,134)

 

7,337

Property additions

 

-

 

3,329

 

-

 

3,329

Depreciation and amortization

 

-

 

2,640

 

1,202

 

3,842

Total assets

 

2,343,236

 

1,657,984

 

764,633

 

4,765,853